1
|
Bhilare NV, Marulkar VS, Shirote PJ, Dombe SA, Pise VJ, Salve PL, Biradar SM, Yadav VD, Jadhav PD, Bodhe AA, Borkar SP, Ghadge PM, Shelar PA, Jadhav AV, Godse KC. Mannich Bases: Centrality in Cytotoxic Drug Design. Med Chem 2021; 18:735-756. [PMID: 34931967 DOI: 10.2174/1573406418666211220124119] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2021] [Revised: 10/04/2021] [Accepted: 10/18/2021] [Indexed: 11/22/2022]
Abstract
Mannich bases identified by Professor Carl Mannich have been the most extensively explored scaffolds for more than 100 years now. The versatile biological roles that they play have promoted their applications in many clinical conditions. The present review highlights the application of Mannich bases as cytotoxic agents, categorizing them into synthetic, semisynthetic and prodrugs classes and gives an exhaustive account of the work reported in the last two decades. The methods of synthesis of these cytotoxic agents, their anti-cancer potential in various cell lines and promising leads for future drug development have also been discussed. Structure-activity relationships along with the targets on which these cytotoxic Mannich bases act have been included as well.
Collapse
Affiliation(s)
- Neha V Bhilare
- Department of Pharmaceutical Chemistry, Arvind Gavali College of Pharmacy, Satara-415004, Maharashtra, India
| | - Vinayak S Marulkar
- Department of Pharmaceutical Chemistry, Arvind Gavali College of Pharmacy, Satara-415004, Maharashtra, India
| | - Pramodkumar J Shirote
- Department of Pharmaceutical Chemistry, Arvind Gavali College of Pharmacy, Satara-415004, Maharashtra, India
| | - Shailaja A Dombe
- Department of Pharmaceutics, Arvind Gavali College of Pharmacy, Satara-415004, Maharashtra, India
| | - Vilas J Pise
- Department of Pharmaceutical Chemistry, Arvind Gavali College of Pharmacy, Satara-415004, Maharashtra, India
| | - Pallavi L Salve
- Department of Pharmaceutical Chemistry, Arvind Gavali College of Pharmacy, Satara-415004, Maharashtra, India
| | - Shantakumar M Biradar
- Department of Pharmaceutical Chemistry, Arvind Gavali College of Pharmacy, Satara-415004, Maharashtra, India
| | - Vishal D Yadav
- Department of Pharmaceutics, Arvind Gavali College of Pharmacy, Satara-415004, Maharashtra, India
| | - Prakash D Jadhav
- Department of Pharmaceutics, Arvind Gavali College of Pharmacy, Satara-415004, Maharashtra, India
| | - Anjali A Bodhe
- Department of Pharmaceutics, Arvind Gavali College of Pharmacy, Satara-415004, Maharashtra, India
| | - Smita P Borkar
- Department of Pharmaceutics, Arvind Gavali College of Pharmacy, Satara-415004, Maharashtra, India
| | - Prachi M Ghadge
- Department of Pharmacology, Arvind Gavali College of Pharmacy, Satara-415004, Maharashtra, India
| | - Pournima A Shelar
- Department of Pharmaceutics, Arvind Gavali College of Pharmacy, Satara-415004, Maharashtra, India
| | - Apurva V Jadhav
- Department of Pharmaceutics, Arvind Gavali College of Pharmacy, Satara-415004, Maharashtra, India
| | - Kirti C Godse
- Department of Pharmacology, Arvind Gavali College of Pharmacy, Satara-415004, Maharashtra, India
| |
Collapse
|
2
|
Dudhe AC, Dudhe R, Porwal O, Katole G. An Overview of Synthesis and Biological Activity of Dihydropyrimidine Derivatives. Mini Rev Med Chem 2021; 22:701-728. [PMID: 34544334 DOI: 10.2174/1389557521666210920120457] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2020] [Revised: 05/12/2021] [Accepted: 08/04/2021] [Indexed: 11/22/2022]
Abstract
Dihydropyrimidine derivatives are most important scaffolds due to structure similarities with natural products it is a hetrocyclic compound. The chemistry of Dihydropyrimidine is a blossoming field. Various reaction schemes for the preparation of Dihydropyrimidines and produce different biological effect and offer vast scope in the field of medicinal chemistry. This article goal to analysis the work reported the recent chemistry and pharmacological activities of dihydropyrimidine derivatives.
Collapse
Affiliation(s)
- Anshu Chaudhary Dudhe
- School of Pharmacy, G H Raisoni University, Saikheda, Saunsar, Chhindwara, M.P. 480337. India
| | - Rupesh Dudhe
- School of Pharmacy, G H Raisoni University, Saikheda, Saunsar, Chhindwara, M.P. 480337. India
| | - Omji Porwal
- Department of Pharmacy, Tishk International University, Pharmacy Faculty, Erbil, KRG. Iraq
| | - Gayatri Katole
- School of Pharmacy, G H Raisoni University, Saikheda, Saunsar, Chhindwara, M.P. 480337. India
| |
Collapse
|
3
|
Wu M, Han J, Liu Z, Zhang Y, Huang C, Li J, Li Z. Identification of novel CDK 9 inhibitors based on virtual screening, molecular dynamics simulation, and biological evaluation. Life Sci 2020; 258:118228. [PMID: 32781071 DOI: 10.1016/j.lfs.2020.118228] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2020] [Revised: 08/03/2020] [Accepted: 08/04/2020] [Indexed: 11/24/2022]
Abstract
AIMS Cyclin-dependent kinase 9 (CDK9) is a member of the CDK subfamily and plays a major role in the regulation of transcriptional elongation. It has attracted widespread attention as a therapeutic target for cancer. Here, we aimed to explore novel CDK 9 inhibitors by using a hybrid virtual screening strategy. MAIN METHODS A hybrid virtual screening strategy was constructed with computer-aided drug design (CADD). First, compounds were filtered in accordance with Lipinski's rule of five and adsorption, distribution, metabolism, excretion, and toxicity (ADMET) properties. Second, a 3D-QSAR pharmacophore model was built and used as a 3D query to screen the obtained hit compounds. Third, the hit compounds were subjected to molecular docking studies. Fourth, molecular dynamics (MD) simulations were performed on CDK9 in complex with the final hits to examine the structural stability. Finally, CDK9 kinase biochemical assay was performed to identify the biological activity of the hit compounds. KEY FINDINGS Seven hit compounds were screened out. These hit compounds showed drug-like properties in accordance with Lipinski's rule of five and ADMET. Complexes involving the six hit compounds bound to CDK9 exhibited good structural stability in the MD simulation. Furthermore, these six hit compounds had strong inhibitory activity against CDK9 kinase. In particular, hit 3 showed the most promising activity with the percentage of 71%. SIGNIFICANCE The six hit compounds may be promising novel CDK9 inhibitors, and the hybrid virtual screening strategy designed in this study provides an important reference for the design and synthesis of novel CDK9 inhibitors.
Collapse
Affiliation(s)
- Mingfei Wu
- The Key Laboratory of Major Autoimmune Diseases, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, The key laboratory of Anti-inflammatory and Immune Medicines, Ministry of Education, Hefei 230032, China
| | - Jianfei Han
- The Key Laboratory of Major Autoimmune Diseases, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, The key laboratory of Anti-inflammatory and Immune Medicines, Ministry of Education, Hefei 230032, China
| | - Zhicheng Liu
- The Key Laboratory of Major Autoimmune Diseases, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, The key laboratory of Anti-inflammatory and Immune Medicines, Ministry of Education, Hefei 230032, China
| | - Yilong Zhang
- The Key Laboratory of Major Autoimmune Diseases, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, The key laboratory of Anti-inflammatory and Immune Medicines, Ministry of Education, Hefei 230032, China
| | - Cheng Huang
- The Key Laboratory of Major Autoimmune Diseases, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, The key laboratory of Anti-inflammatory and Immune Medicines, Ministry of Education, Hefei 230032, China
| | - Jun Li
- The Key Laboratory of Major Autoimmune Diseases, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, The key laboratory of Anti-inflammatory and Immune Medicines, Ministry of Education, Hefei 230032, China.
| | - Zeng Li
- The Key Laboratory of Major Autoimmune Diseases, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, The key laboratory of Anti-inflammatory and Immune Medicines, Ministry of Education, Hefei 230032, China.
| |
Collapse
|